Potential antidepressant overtreatment associated with office use of brief depression symptom measures

Journal of the American Board of Family Medicine

Volumn 27, Issue 5, 2014, Pages 611-620

  Jerant, Anthony ^a,d   Kravitz, Richard L ^b,d   Garcia, Erik Fernandez ^c   Feldman, Mitchell D ^a   Cipri, Camille ^d   Nishio, Denyse ^e   Knoepfler, Anca ^e   Kaleo Wooddell, M ^e   Baquero, Victor ^e   Franks, Peter ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Emergency Medicine   (United States)

^c Division of Pediatric Cardiology   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidepressive Agents; Depression; Health Services Misuse

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; DEPRESSION; EXPLORATORY RESEARCH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; PATIENT HEALTH QUESTIONNAIRE 2; PATIENT HEALTH QUESTIONNAIRE 9; PRESCRIPTION; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; AMBULATORY CARE; DEPRESSIVE DISORDER, MAJOR; DEVICES; DIAGNOSTIC ERROR; DRUG MISUSE; MASS SCREENING; MIDDLE AGED; PRIMARY HEALTH CARE; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; STANDARDS; UNITED STATES;

ANTIDEPRESSIVE AGENTS; CALIFORNIA; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC ERRORS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OFFICE VISITS; PRESCRIPTION DRUG MISUSE; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84907057171     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2014.05.140038     Document Type: Review

References (32)

1. Rost K, Nutting P, Smith J, Coyne JC, Cooper- Patrick L, Rubenstein L. The role of competing demands in the treatment provided primary care patients with major depression. Arch Fam Med 2000; 9:150-4.
2. Bell RA, Franks P, Duberstein PR, et al. Suffering in silence: reasons for not disclosing depression in primary care. Ann Fam Med 2011;9:439-46.
3. Mitchell AJ, Rao S, Vaze A. Do primary care physicians have particular difficulty identifying late-life depression? A meta-analysis stratified by age. Psychother Psychosom 2010;79:285-94.
4. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
5. Lowe B, Kroenke K, Grafe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res 2005;58:163-71.
6. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann 2002;32:509-21.
7. Screening for depression in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 2009;151:784-92.
8. Katz PS. Observer extra: depression. An internist's guide to screening, diagnosing and treating clinical depression. Philadelphia: American College of Physicians; 2006. Available from: http://www.acpinternist. org/archives/2006/12/depression.pdf. Accessed January 13, 2014.
9. Mitchell J, Trangle M, Degnan B, et al. Adult depression in primary care. 16th ed. Bloomington, MN: Institute for Clinical Systems Improvement; 2013. Available from: https://www.icsi.org/asset/fnhdm3/Depr-Interactive0512b.pdf. Accessed January 13, 2014.
10. O'Connor EA, Whitlock EP, Beil TL, Gaynes BN. Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med 2009;151:793-803.
11. Joffres M, Jaramillo A, Dickinson J, et al. Recommendations on screening for depression in adults. CMAJ 2013;185:775-82.
12. Cuijpers P, van Straten A, Andersson G, van Oppen P. Psychotherapy for depression in adults: a metaanalysis of comparative outcome studies. J Consult Clin Psychol 2008;76:909-22.
13. Barbui C, Cipriani A, Patel V, Ayuso-Mateos JL, van Ommeren M. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry 2011;198:11-6, sup 1.
14. Hegerl U, Schonknecht P, Mergl R. Are antidepressants useful in the treatment of minor depression: a critical update of the current literature. Curr Opin Psychiatry 2012;25:1-6.
15. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010;303:47-53.
16. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 2009;374:609-19.
17. Mojtabai R. Clinician-identified depression in community settings: concordance with structured-interview diagnoses. Psychother Psychosom 2013;82: 161-9.
18. Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med 2011;155:772-85.
19. Schmitt MR, Miller MJ, Harrison DL, Touchet BK. Relationship of depression screening and physician office visit duration in a national sample. Psychiatr Serv 2010;61:1126-31.
20. Jaen CR, Stange KC, Nutting PA. Competing dedoi mands of primary care: a model for the delivery of clinical preventive services. J Fam Pract 1994;38: 166-71.
21. Parchman ML, Pugh JA, Romero RL, Bowers KW. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med 2007;5:196-201.
22. Kravitz RL, Franks P, Feldman MD, et al. Targeted and tailored patient engagement programs for recognition and initial treatment of depression in primary care: a randomized trial. JAMA 2013;310: 1818-28.
23. Aikens JE, Nease DE Jr, Klinkman MS. Explaining patients' beliefs about the necessity and harmfulness of antidepressants. Ann Fam Med 2008;6:23-9.
24. Johnson MD, Meredith LS, Hickey SC, Wells KB. Influence of patient preference and primary care clinician proclivity for watchful waiting on receipt of depression treatment. Gen Hosp Psychiatry 2006;28: 379-86.
25. van Schaik DJ, Klijn AF, van Hout HP, et al. Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry 2004; 26:184-9.
26. Esserman LJ, Thompson IM, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 2013;310:797-8.
27. Lauer MS. Pseudodisease, the next great epidemic in coronary atherosclerosis?: comment on "Impact of coronary computed tomographic angiography results on patient and physician behavior in a low-risk population". Arch Intern Med 2011;171:1268-9.
28. Tancredi DJ, Slee CK, Jerant A, et al. Targeted versus tailored multimedia patient engagement to enhance depression recognition and treatment in primary care: randomized controlled trial protocol for the AMEP2 study. BMC Health Serv Res 2013; 13:141.
29. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009;114:163-73.
30. Ware J Jr, Kosinski M, Keller SD. A 12-item Short- Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
31. Mojtabai R. Diagnosing depression and prescribing antidepressants by primary care physicians: the impact of practice style variations. Ment Health Serv Res 2002;4:109-18.
32. Jerant A, Sohler N, Fiscella K, Franks B, Franks P. Tailored interactive multimedia computer programs to reduce health disparities: opportunities and challenges. Patient Educ Couns 2011;85:323-30.